Skip Navigation

Orlando Health Cancer Institute

Location

Orlando Health Cancer Institute
1400 South Orange Avenue
Orlando, FL 32806
Direct phone: 321-843-8010

Total transplants by cell source

From January 1, 2020 to December 31st, 2021
  • Marrow: 1
  • PBSC: 20
  • Cord Blood: 0
  • Autologous (PBSC or Marrow): 15
Performs adult transplants

Overview

Established in 2020 Orlando Health Cancer Institute’s Bone Marrow Transplant & Cellular Therapy program is part of the state-of-the-art, 10-story Charles Lewis Pavilion on the downtown Orlando campus. The program provides cellular therapy and stem cell transplantation for patients with conditions such as leukemia, lymphoma, multiple myeloma, bone marrow failures, and aplastic anemias. We offer autologous as well as allogeneic transplantation using all donor sources being matched siblings, unrelated donors, and alternative sources such as haploidentical and cord blood. The program offers inpatient and ambulatory services. Our institution obtained FACT accreditation February 1, 2023.

This center has been performing allogeneic transplants since 2021 and has been an NMDP/Be The Match transplant center since April 2022.

Attending physicians

Adult - Samer Kahled, Yasser Khaled, Juan Carlos Varela

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Adult only

Other programs and services

This institute is a certified center for CAR T cell therapy treating Acute Lymphocytic Leukemia, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Multiple Myeloma.

Discounts with local hotels and short-term lodging.

Our Integrative Medicine Department offers a wide array of therapeutic support and interventions. These services include art classes, yoga, oncology medical massages, music therapy, support groups, crisis line, and patient & family counseling.

About the center

Overview

Established in 2020 Orlando Health Cancer Institute’s Bone Marrow Transplant & Cellular Therapy program is part of the state-of-the-art, 10-story Charles Lewis Pavilion on the downtown Orlando campus. The program provides cellular therapy and stem cell transplantation for patients with conditions such as leukemia, lymphoma, multiple myeloma, bone marrow failures, and aplastic anemias. We offer autologous as well as allogeneic transplantation using all donor sources being matched siblings, unrelated donors, and alternative sources such as haploidentical and cord blood. The program offers inpatient and ambulatory services. Our institution obtained FACT accreditation February 1, 2023.

This center has been performing allogeneic transplants since 2021 and has been an NMDP/Be The Match transplant center since April 2022.

Attending physicians

Adult - Samer Kahled, Yasser Khaled, Juan Carlos Varela

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on

Adult only

Other programs and services

This institute is a certified center for CAR T cell therapy treating Acute Lymphocytic Leukemia, Mantle Cell Lymphoma, Non-Hodgkins Lymphoma, and Multiple Myeloma.

Discounts with local hotels and short-term lodging.

Our Integrative Medicine Department offers a wide array of therapeutic support and interventions. These services include art classes, yoga, oncology medical massages, music therapy, support groups, crisis line, and patient & family counseling.

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are above the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 20 patients.

The actual 1-year survival of these patients is 80.0%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 38.6% and 78.3%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Total transplants

Total transplants


36

Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 1 6 0 7
Unrelated donor 0 14 0 14
Total allogeneic 1 20 0 21
Autologous
Both marrow & PBSC
15
-- 15
Total combined
36 0 36

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 0 3 4 0 7
Unrelated 0 1 8 5 14
Autologous 0 0 11 4 15
Total 0 4 23 9 36

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

Transplant center coordinator:
Deborah Isayyid
321-841-4198
Email: deborah.isayyid@orlandohealth.com

If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.

Be The Match patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program


No survivorship program information is available. Contact the center for information about post-transplant care.